Design of synthetic antimicrobial peptides based on sequence analogy and amphipathicity.

Novel alpha-helical antimicrobial peptides have been devised by comparing the N-terminal sequences of many of these peptides from insect, frog and mammalian families, extracting common features, and creating sequence templates with which to design active peptides. Determination of the most frequent amino acids in the first 20 positions for over 80 different natural sequences allowed the design of one peptide, while a further three were based on the comparison of the sequences of alpha-helical antimicrobial peptides derived from the mammalian cathelicidin family of precursors. These peptides were predicted to assume a highly amphipathic alpha-helical conformation, as indicated by high mean hydrophobic moments. In fact, circular dichroism experiments showed clear transitions from random coil in aqueous solution to an alpha-helical conformation on addition of trifluoroethanol. All four peptides displayed a potent antibacterial activity against selected gram-positive and gram-negative bacteria (minimum inhibitory concentrations in the range 1-8 microM), including some antibiotic resistant strains. Permeabilization of both the outer and cytoplasmic membranes of the gram-negative bacterium, Escherichia coli, by selected peptides was quite rapid and a dramatic drop in colony forming units was observed within 5 min in time-killing experiments. Permeabilization of the cytoplasmic membrane of the gram-positive bacterium, Staphylococcus aureus, was instead initially quite slow, gathering speed after 45 min, which corresponds to the time required for significant inactivation in time-killing studies. The cytotoxic activity of the peptides, determined on several normal and transformed cell lines, was generally low at values within the minimum inhibitory concentration range.

[1]  PMAP-37, a novel antibacterial peptide from pig myeloid cells. cDNA cloning, chemical synthesis and activity. , 1995, European journal of biochemistry.

[2]  A. Mor,et al.  The NH2-terminal alpha-helical domain 1-18 of dermaseptin is responsible for antimicrobial activity. , 1994, The Journal of biological chemistry.

[3]  W. J. Waddell,et al.  A simple ultraviolet spectrophotometric method for the determination of protein. , 1956, The Journal of laboratory and clinical medicine.

[4]  R. B. Merrifield,et al.  N-terminal analogues of cecropin A: synthesis, antibacterial activity, and conformational properties. , 1985, Biochemistry.

[5]  J. Grivet,et al.  Interactions of basic amphiphilic peptides with dimyristoylphosphatidylcholine small unilamellar vesicles: optical, NMR, and electron microscopy studies and conformational calculations. , 1993, Biochemistry.

[6]  W. Maloy,et al.  Structure–activity studies on magainins and other host defense peptides , 1995, Biopolymers.

[7]  Hao‐Chia Chen,et al.  Synthetic magainin analogues with improved antimicrobial activity , 1988, FEBS letters.

[8]  A. Mor,et al.  Peptides as weapons against microorganisms in the chemical defense system of vertebrates. , 1995, Annual review of microbiology.

[9]  R. B. Merrifield,et al.  The chemical synthesis of cecropin D and an analog with enhanced antibacterial activity. , 1989, The Journal of biological chemistry.

[10]  Domenico Romeo,et al.  Cathelicidins: a novel protein family with a common proregion and a variable C‐terminal antimicrobial domain , 1995, FEBS letters.

[11]  P. Storici,et al.  An approach combining rapid cDNA amplification and chemical synthesis for the identification of novel, cathelicidin-derived, antimicrobial peptides. , 1997, Methods in molecular biology.

[12]  J. Larrick,et al.  The solution structure of the active domain of CAP18 — a lipopolysaccharide binding protein from rabbit leukocytes , 1995, FEBS letters.

[13]  J. Larrick,et al.  Human CAP18: a novel antimicrobial lipopolysaccharide-binding protein , 1995, Infection and immunity.

[14]  S. Ludtke,et al.  Membrane thinning caused by magainin 2. , 1995, Biochemistry.

[15]  M. Zasloff,et al.  Antimicrobial activity of synthetic magainin peptides and several analogues. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[16]  P. Storici,et al.  PMAP-37, a novel antibacterial peptide from pig myeloid cells. cDNA cloning, chemical synthesis and activity. , 1995, European journal of biochemistry.

[17]  N. Fujii,et al.  An antimicrobial peptide, magainin 2, induced rapid flip-flop of phospholipids coupled with pore formation and peptide translocation. , 1996, Biochemistry.

[18]  R A Houghten,et al.  Design of model amphipathic peptides having potent antimicrobial activities. , 1992, Biochemistry.

[19]  J. Odeberg,et al.  FALL-39, a putative human peptide antibiotic, is cysteine-free and expressed in bone marrow and testis. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[20]  H. G. Boman,et al.  Peptide antibiotics and their role in innate immunity. , 1995, Annual review of immunology.

[21]  E. Rietschel,et al.  Chemical structure of the lipid A component of the lipopolysaccharide from a Proteus mirabilis Re-mutant. , 1983, European journal of biochemistry.

[22]  P. Storici,et al.  Chemical synthesis and biological activity of a novel antibacterial peptide deduced from a pig myeloid cDNA , 1994, FEBS letters.

[23]  J. Dufourcq,et al.  The amphipathic α‐helix concept , 1994 .

[24]  Y. Kirino,et al.  Interaction with phospholipid bilayers, ion channel formation, and antimicrobial activity of basic amphipathic alpha-helical model peptides of various chain lengths. , 1991, The Journal of biological chemistry.

[25]  R. Gennaro,et al.  Rapid membrane permeabilization and inhibition of vital functions of gram-negative bacteria by bactenecins , 1990, Infection and immunity.

[26]  London Wc,et al.  De Novo Antimicrobial Peptides with Low Mammalian Cell Toxicity , 1996 .

[27]  B. Cooperman,et al.  Protein estimation by the product of integrated peak area and flow rate. , 1989, Analytical biochemistry.

[28]  T. Ganz,et al.  Defensins and other endogenous peptide antibiotics of vertebrates , 1995, Journal of leukocyte biology.

[29]  Y H Chen,et al.  Determination of the helix and beta form of proteins in aqueous solution by circular dichroism. , 1974, Biochemistry.

[30]  R. Gennaro,et al.  Identification and characterization of a primary antibacterial domain in CAP18, a lipopolysaccharide binding protein from rabbit leukocytes , 1994, FEBS letters.

[31]  Y. Shai,et al.  Interaction of antimicrobial dermaseptin and its fluorescently labeled analogues with phospholipid membranes. , 1992, Biochemistry.

[32]  R. Houghten,et al.  Rapid identification of compounds with enhanced antimicrobial activity by using conformationally defined combinatorial libraries. , 1996, The Biochemical journal.

[33]  D. Eisenberg,et al.  Analysis of membrane and surface protein sequences with the hydrophobic moment plot. , 1984, Journal of molecular biology.

[34]  W. Hengstenberg,et al.  Phosphotransferase System of Staphylococcus aureus: Its Requirement for the Accumulation and Metabolism of Galactosides , 1969, Journal of bacteriology.

[35]  B. Lenarčič,et al.  Purification and structural characterization of bovine cathelicidins, precursors of antimicrobial peptides. , 1996, European journal of biochemistry.

[36]  S J Ludtke,et al.  Membrane pores induced by magainin. , 1996, Biochemistry.

[37]  N. Fujii,et al.  Molecular basis for membrane selectivity of an antimicrobial peptide, magainin 2. , 1995, Biochemistry.

[38]  J. Hoffmann,et al.  The inducible antibacterial peptides of insects. , 1994, Parasitology today.

[39]  R. B. Merrifield,et al.  Antibacterial and antimalarial properties of peptides that are cecropin‐melittin hybrids , 1989, FEBS letters.

[40]  D. Desiderio,et al.  Structure-function studies of amphiphilic antibacterial peptides. , 1993, Journal of medicinal chemistry.

[41]  B. Rost,et al.  Prediction of protein secondary structure at better than 70% accuracy. , 1993, Journal of molecular biology.

[42]  R A Houghten,et al.  Novel antimicrobial compounds identified using synthetic combinatorial library technology. , 1996, Trends in biotechnology.

[43]  W. M. Vos,et al.  Maturation pathway of nisin and other lantibiotics: post‐translationally modified antimicrobial peptides exported by Gram‐positive bacteria , 1995, Molecular microbiology.

[44]  D. McCarthy,et al.  Comparison of the effects of hydrophobicity, amphiphilicity, and α‐helicity on the activities of antimicrobial peptides , 1995, Proteins.

[45]  N. Fujii,et al.  Orientational and aggregational states of magainin 2 in phospholipid bilayers. , 1994, Biochemistry.

[46]  S. Opella,et al.  Structure and orientation of the antibiotic peptide magainin in membranes by solid‐state nuclear magnetic resonance spectroscopy , 1993, Protein science : a publication of the Protein Society.

[47]  R. Nagaraj,et al.  Cell-lytic and antibacterial peptides that act by perturbing the barrier function of membranes: facets of their conformational features, structure-function correlations and membrane-perturbing abilities. , 1994, Biochimica et biophysica acta.

[48]  R. Gennaro,et al.  Purification, composition, and activity of two bactenecins, antibacterial peptides of bovine neutrophils , 1989, Infection and immunity.

[49]  H. Sahl Gene-encoded antibiotics made in bacteria. , 1994, Ciba Foundation symposium.

[50]  L. Bagella,et al.  cDNA sequences of three sheep myeloid cathelicidins , 1995, FEBS letters.

[51]  A. Lee,et al.  Molecular analysis of the sheep cathelin family reveals a novel antimicrobial peptide , 1995, FEBS letters.

[52]  L. Bagella,et al.  Biological Characterization of Two Novel Cathelicidin-derived Peptides and Identification of Structural Requirements for Their Antimicrobial and Cell Lytic Activities* , 1996, The Journal of Biological Chemistry.

[53]  D. Barra,et al.  Amphibian skin: a promising resource for antimicrobial peptides. , 1995, Trends in biotechnology.

[54]  A. Rao,et al.  Design and synthesis of amphipathic antimicrobial peptides. , 2009, International journal of peptide and protein research.

[55]  C. Kozak,et al.  Identification of CRAMP, a Cathelin-related Antimicrobial Peptide Expressed in the Embryonic and Adult Mouse* , 1997, The Journal of Biological Chemistry.

[56]  J. Larrick,et al.  Antimicrobial activity of rabbit CAP18-derived peptides , 1993, Antimicrobial Agents and Chemotherapy.

[57]  R. Hancock Alterations in outer membrane permeability. , 1984, Annual review of microbiology.

[58]  R. Houghten,et al.  The Magainins: sequence factors relevant to increased antimicrobial activity and decreased hemolytic activity. , 1988, Peptide research.